Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares rose 1.8% on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The stock has a fifty day moving average price of C$0.58 and a 200-day moving average price of C$0.58. The firm has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Quiet Period Expirations Explained
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Most active stocks: Dollar volume vs share volume
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
